Fanni A Boros
Overview
Explore the profile of Fanni A Boros including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saarela D, Lis P, Gomes S, Nirujogi R, Dong W, Rawat E, et al.
J Clin Invest
. 2024 Dec;
135(4).
PMID: 39724071
Lysosomes are implicated in a wide spectrum of human diseases, including monogenic lysosomal storage disorders (LSDs), age-associated neurodegeneration, and cancer. Profiling lysosomal content using tag-based lysosomal immunoprecipitation (LysoTagIP) in cell...
2.
Maszlag-Torok R, Boros F, Vecsei L, Klivenyi P
Sci Rep
. 2021 May;
11(1):10677.
PMID: 34021216
Parkinson's disease (PD) is a neurodegenerative disease caused by complex interaction between genetic and environmental factors. There is a growing body of evidence of the involvement of sirtuins (SIRTs) in...
3.
Boros F, Vecsei L
Front Immunol
. 2019 Nov;
10:2570.
PMID: 31781097
Several enzymes and metabolites of the kynurenine pathway (KP) have immunomodulatory effects. Modulation of the activities and levels of these molecules might be of particular importance under disease conditions when...
4.
Boros F, Torok R, Vagvolgyi-Sumegi E, Pesei Z, Klivenyi P, Vecsei L
Neurosci Lett
. 2019 May;
706:140-145.
PMID: 31085292
Introduction: Parkinson's disease is the second most common neurodegenerative disease. Lifestyle, environmental effects and several genetic factors have been proposed to contribute to its development. Though the majority of PD...
5.
Boros F, Klivenyi P, Toldi J, Vecsei L
Expert Opin Ther Targets
. 2018 Nov;
23(1):39-51.
PMID: 30449219
Huntington's disease (HD) is an autosomal dominant, neurodegenerative disorder. Despite the severe motor, psychiatric and cognitive symptoms and the great socioeconomic burden caused by the disease, available treatment is mainly...
6.
Boros F, Bohar Z, Vecsei L
Mutat Res Rev Mutat Res
. 2018 May;
776:32-45.
PMID: 29807576
Tryptophan is metabolized primarily via the kynurenine pathway (KP), which involves several enzymes, including indoleamine 2,3-dioxygenase, tryptophan 2,3 dioxygenase (TDO), kynurenine aminotransferases (KATs), kynurenine monooxygenase (KMO) etc. The majority of...